CURE's Stochastic Oscillator remains in overbought zone for 1 day
Expect a price pull-back in the near future.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for CURE crossed bearishly below the 50-day moving average on July 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CURE entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 14, 2025. You may want to consider a long position or call options on CURE as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CURE just turned positive on August 14, 2025. Looking at past instances where CURE's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
CURE moved above its 50-day moving average on August 15, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .
CURE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Advertisement
General Information
Category Trading
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LMGAX | 29.09 | 0.08 | +0.28% |
| Lord Abbett Growth Opportunities A | |||
| CMCCX | 16.28 | 0.03 | +0.18% |
| Columbia Select Mid Cap Gro Fd C | |||
| NLSIX | 19.90 | 0.03 | +0.15% |
| Neuberger Berman Long Short Instl | |||
| PBSIX | 15.68 | -0.06 | -0.38% |
| Polen US Small Company Growth Instl | |||
| SKSEX | 29.93 | -0.22 | -0.73% |
| AMG GW&K Small Cap Value N | |||
CURE and ETFs
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with SPXL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then SPXL could also see price increases.
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +5.04% | ||
| SPXL - CURE | 59% Loosely correlated | -0.73% | ||
| SSO - CURE | 58% Loosely correlated | -0.49% | ||
| TQQQ - CURE | 47% Loosely correlated | -1.42% | ||
| QLD - CURE | 46% Loosely correlated | -0.94% | ||
| SOXL - CURE | 43% Loosely correlated | -6.97% | ||
More | ||||